Everest Medicines Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,129.00
-933.00
-287.00
-1,215.00
-6,358.00
-243.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-185.00
-89.00
-34.00
41.00
85.00
96.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-758.00
-858.00
-1,344.00
-879.00
-530.00
-100.00
Cash Flow from Investing Activities
1,056.00
831.00
-1,195.00
-1,176.00
-584.00
-53.00
Cash Flow from Financing Activities
62.00
19.00
-29.00
-92.00
6,335.00
70.00
Net Cash Inflow / Outflow
391.00
35.00
-2,499.00
-2,218.00
4,916.00
-87.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
31.00
42.00
69.00
-70.00
-304.00
-3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Everest Medicines Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-1129.08360398801
3031.78945488905
-4,160.00
-137.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-185.481425408754
-142.662031011613
-43.00
-30.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-758.086058007543
3247.35294462882
-4,005.00
-123.34%
Cash Flow from Investing Activities
1056.46337524091
-701.200990415134
1,757.00
250.66%
Cash Flow from Financing Activities
62.3255233625224
-2727.61117846627
2,789.00
102.28%
Net Cash Inflow / Outflow
391.843917800299
-171.903409566887
562.00
327.94%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
31.1410772044111
9.55581468569306
22.00
225.89%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 11.72% vs 36.11% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-758.09
-858.73
11.72%






